Shop
Your Account Sign In
Support Us
Subscribe
Britain World Editorial Features Culture Sport
Britain World Editorial Features Culture Sport
Climate Crisis Far Right Gaza Workers' Rights Labour Party Morning Star Video
Latest editorial
Hypocritical US ‘free speech’ concerns are an opportunity for the left to reclaim that vital cause
Advertise Contact us Shop Subscribe Support us Daily Alert
Climate Crisis Far Right Gaza Workers' Rights Labour Party Morning Star Video
Gifts from The Morning Star
Britain / 15 August 2022
Concerns raised over pharma monopolies as ‘next generation’ covid jab approved
File photo dated 31/07/21 of a person receiving a Covid-19 jab
Michael Selby-Green
Recent
Palestinians carry the body of Al Jazeera correspondent Anas al-Sharif at his funeral outside Gaza City's Shifa hospital complex, August 11, 2025
British Foreign Policy / 14 August 2025
Gazans in Britain call on government for action on journalists' killings
14 August 2025
Monarchy / 14 August 2025
Free King Charles portrait rejected by 46,000 public institutions
14 August 2025
Arms Trade / 14 August 2025
Rolls-Royce making fortune from ‘untested new nuclear market’
14 August 2025

Campaign for Nuclear Disarmament condemns the firm's plans for AI-assisted small modular reactors

Scotland / 14 August 2025
Anti-genocide protesters greet US Vice-president JD Vance in Ayrshire
14 August 2025
Housing Crisis / 14 August 2025
No-fault evictions by bailiffs up in Labour's first year
14 August 2025
Education / 14 August 2025
NEU warns against ‘one size fits all’ exams system on A-level results day
14 August 2025
Cost-of Living Crisis / 14 August 2025
Students at ‘breaking point’ as half of undergraduates say financial worries hurts their mental health
14 August 2025
Donate to the Morning Star Fighting Fund
Morning Star Shop

CAMPAIGNERS raised concerns over pharmaceutical monopolies today as a “next generation” coronavirus booster jab needed only once a year was approved for use in adults in Britain.

The UK Medicines & Healthcare products Regulatory Agency authorised the new Covid-19 injection from US pharmaceutical giant Moderna.

It is an updated version of the Moderna jab that has already been in use with some people who got their first, second or booster injections.

The 95th Anniversary Appeal
Support the Morning Star
You have reached the free limit.
Subscribe to continue reading.
Become a subscriber
More from this author
Minister without Portfolio Nadhim Zahawi arrives in Downing
Britain / 15 January 2023
Former chancellor Zahawi agrees to pay millions in tax following questions over his finances
15 January 2023
Britain / 13 January 2023
Scottish Greens call on Westminster to ‘wake up to the reality of the climate crisis’
13 January 2023
Britain / 13 January 2023
Cost of dying soars by 3.8 percent
13 January 2023
A child’s shoe and clothes are left at a site of Saudi-led
Britain / 10 January 2023
British arms have contributed to ‘pattern of violence against civilians’ in Yemen, Oxfam report finds
10 January 2023
Similar stories
Tedros Adhanom Ghebreyesus, Director General of the World Health Organization (WHO), applauds as member countries approve an agreement to combat future pandemics, in Geneva, Switzerland, May 20, 2025
World Health Organisation / 20 May 2025
WHO member countries approve new pandemic agreement
20 May 2025
POISON: Centivax workers study antivenom to counteract the bites of various snakes at the company lab in San Francisco
Science and Society / 7 May 2025
Bite me: Venom, volunteers and venture capital
7 May 2025

A maverick’s self-inflicted snake bites could unlock breakthrough treatments – but they also reveal deeper tensions between noble scientific curiosity and cold corporate callousness, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT

LINING THEIR POCKETS: Gilead Sciences HQ in Foster City, Cal
Science and Society / 18 December 2024
Patents: how the profit machine costs lives
18 December 2024
Despite miraculous trial results showing new treatment could halt transmission, corporate greed and patent laws condemn millions to preventable infection and death, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
An electron micrograph of HIV-1 virus particles (colourized
Features / 13 September 2024
Public pharma v abusive prices: the case of the latest HIV-prevention drug
13 September 2024
ALAN ROSSI SILVA argues that Gilead’s HIV prevention drug, while promising, highlights systemic failures in the pharmaceutical industry, showing the need to shift towards state-owned drug development and production